Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.10.0.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Income Statement [Abstract]        
Net sales $ 170,684 $ 252,000 $ 730,913 $ 1,822,037
Cost of sales 1,655,905 995,925 3,370,275 5,308,013
Gross loss (1,485,221) (743,925) (2,639,362) (3,485,976)
Operating Expenses        
Selling, general and administrative 3,003,202 2,601,590 5,403,349 4,501,172
Research and development 1,894,712 5,811,333 4,232,343 9,054,655
Total operating expenses 4,897,914 8,412,923 9,635,692 13,555,827
Interest expense, net 526,162 21,852 1,052,049 57,503
Net loss (6,909,297) (9,178,700) (13,327,103) (17,099,306)
Deemed dividend - September 2017 Warrants 765,179 765,179
Net loss attributable to common stockholders $ (7,674,476) $ (9,178,700) $ (14,092,282) $ (17,099,306)
Net loss attributable to common stockholders per share - basic and diluted $ (0.18) $ (0.26) $ (0.33) $ (0.48)
Weighted average number of common shares outstanding 42,406,471 35,273,462 42,406,471 35,273,462